Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?

Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142:14–22. https://doi.org/10.1111/ane.13266.

CAS  Article  PubMed  Google Scholar 

Sfera A, Osorio C, Maguire G, Rahman L, Afzaal J, Cummings M, et al. COVID-19, ferrosenescence and neurodegeneration, a mini-review. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;109: 110230. https://doi.org/10.1016/j.pnpbp.2020.110230.

CAS  Article  Google Scholar 

Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856–60. https://doi.org/10.1126/science.abd2985.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jiang S, Hillyer C, Du L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020;41:5. https://doi.org/10.1016/j.it.2020.03.007.

CAS  Article  Google Scholar 

Xu J, Lazartigues E. Expression of ACE2 in human neurons supports the neuro-invasive potential of COVID-19 virus. Cell Mol Neurobiol. 2020;42(1):305–9. https://doi.org/10.1007/s10571-020-00915-1.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lima M, Siokas V, Aloizou AM, Liampas L, Mentis AFA, Tsouris Z, et al. Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system. Curr Treat Options Neurol. 2020;22:37. https://doi.org/10.1007/s11940-020-00647-z.

Article  PubMed  PubMed Central  Google Scholar 

Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92:699–702. https://doi.org/10.1002/jmv.25915.

CAS  Article  PubMed  Google Scholar 

Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, et al. Nanobased platforms for diagnosis and treatment of COVID-19: from benchtop to bedside. ACS Biomater Sci Eng. 2021;7:2150–76. https://doi.org/10.1021/acsbiomaterials.1c00318.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Morris M, Zohrabian VM. Neuroradiologists, be mindful of the neuroinvasive potential of COVID-19. Am J Neuroradiol. 2020;41:6. https://doi.org/10.3174/ajnr.A6551.

Article  Google Scholar 

Welcome MO, Mastorakis NE. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021;29:4. https://doi.org/10.1007/s10787-021-00806-x.

CAS  Article  Google Scholar 

Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: a comprehensive review. Rev Neurosci. 2021;32:219–34. https://doi.org/10.1515/revneuro-2020-0070.

CAS  Article  PubMed  Google Scholar 

Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386. https://doi.org/10.3389/fncel.2018.00386.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS-CoV-2: At the crossroad between aging and meurodegeneration. Mov Disord. 2020;35:5. https://doi.org/10.1002/mds.28084.

CAS  Article  Google Scholar 

Jungreis I, Sealfon R, Kellis M. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. Nat Commun. 2021;12:2642. https://doi.org/10.1038/s41467-021-22905-7.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, et al. Drug for corona virus: A systematic review. Indian J Pharmacol. 2020;52:1. https://doi.org/10.4103/ijp.IJP_115_20.

Article  PubMed  PubMed Central  Google Scholar 

Shi CS, Nabar NR, Huang NN, Kehrl JH. SARS-coronavirus open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5:1. https://doi.org/10.1038/s41420-019-0181-7.

CAS  Article  Google Scholar 

Morin CM, Bjorvatn B, Chung F, Holzinger B, Partinen M, Penzel T, et al. Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study. Sleep Med. 2021;87:385–445. https://doi.org/10.1016/j.sleep.2021.07.035.

Article  Google Scholar 

Costello F, Dalakas MC. Cranial neuropathies and COVID-19. Neurology. 2020;95:5. https://doi.org/10.1212/WNL.0000000000009921.

CAS  Article  Google Scholar 

McQuaid C, Brady M, Deane R. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS. 2021;18:32. https://doi.org/10.1186/s12987-021-00267-y.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. 2019;10:1008. https://doi.org/10.3389/fphar.2019.01008.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Sen R, Garbati M, Bryant K, Lu Y. Epigenetic mechanisms influencing COVID-19. Genome. 2021;64:372–85. https://doi.org/10.1139/gen-2020-0135.

CAS  Article  PubMed  Google Scholar 

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22. https://doi.org/10.1016/j.bbi.2020.03.031.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565–71. https://doi.org/10.1038/s41586-021-03710-0.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, Pedro-Murillo ES, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95:e601–5. https://doi.org/10.1212/WNL.0000000000009619.

CAS  Article  PubMed  Google Scholar 

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268–70. https://doi.org/10.1056/NEJMc2008597.

Article  PubMed  Google Scholar 

Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nat Neurosci. 2021;24:368–78. https://doi.org/10.1038/s41593-020-00771-8.

CAS  Article  PubMed  Google Scholar 

Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside. NPJ Park Dis. 2020;6:1. https://doi.org/10.1038/s41531-020-00123-0.

CAS  Article  Google Scholar 

Cascella M, De Blasio E. Pathophysiology of COVID-19-associated neurotoxicity. In: Features and Management of Acute and Chronic Neuro-Covid, Cham: Springer International Publishing, 2022, pp. 1–41.

Jacob A, Alexander JJ. Complement and blood–brain barrier integrity. Mol Immunol. 2014;61:2. https://doi.org/10.1016/j.molimm.2014.06.039.

CAS  Article  Google Scholar 

Jiang Y, Li J, Teng Y, Sun H, Tian G, He L, et al. Complement receptor C5aR1 inhibition reduces pyroptosis in hDPP4-transgenic mice infected with MERS-CoV. Viruses. 2019;11:1. https://doi.org/10.3390/v11010039.

CAS  Article  Google Scholar 

Rojas M, Restrepo-Jiménez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100–23. https://doi.org/10.1016/j.jaut.2018.10.012.

CAS  Article  PubMed  Google Scholar 

Kasperkiewicz M. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention. Cell Stress Chaperones. 2021;26:1–2. https://doi.org/10.1007/s12192-020-01180-3.

CAS  Article  PubMed  Google Scholar 

Lucchese G, Flöel A. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020;25:5. https://doi.org/10.1007/s12192-020-01145-6.

CAS  Article  Google Scholar 

McWilliam M, Samuel M, Alkufri FH. Neuropathic pain post-COVID-19: a case report. BMJ Case Rep. 2021;14:7. https://doi.org/10.1136/BCR-2021-243459.

Article  Google Scholar 

Mangalmurti N, Hunter CA. Cytokine storms: Understanding COVID-19. Immunity. 2020;53:19–25. https://doi.org/10.1016/j.immuni.2020.06.017.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020;40:37. https://doi.org/10.1186/s41232-020-00146-3.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Pensato U, Muccioli L, Janigro D, Guarino M, Bisulli F, Cortelli P. Akinetic mutism in COVID-19-related encephalopathy: a cytokine-mediated maladaptive sickness behavioral response? Brain Behav Immun Heal. 2021;15: 100272. https://doi.org/10.1016/j.bbih.2021.100272.

Article  Google Scholar 

Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020;88:2. https://doi.org/10.1002/ana.25783.

CAS  Article  Google Scholar 

Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A, et al. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 2020;20:1. https://doi.org/10.1186/s12883-020-01812-2.

CAS  Article 

留言 (0)

沒有登入
gif